+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peptic Ulcer Drugs Market by Product (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker), Antacids, H2-Antagonists, Antibiotics, Ulcer protective), Ulcer Type, Distribution Channel, and Region 2023-2028

  • PDF Icon

    Report

  • 143 Pages
  • January 2023
  • Region: Global
  • IMARC Group
  • ID: 5732657
Description Jump to:
The global peptic ulcer drugs market size reached US$ 4.63 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 5.96 Billion by 2028, exhibiting a CAGR of 4.3% during 2022-2028. The increasing prevalence of peptic ulcers, especially amongst the geriatric population and shifting consumer inclination toward various medications over invasive surgeries represent some of the key factors driving the market.

Peptic ulcers, or duodenal ulcers, are open sore that gradually develops and triggers defects in the lining of the stomach, small intestine, and lower esophagus. They are usually caused due to inflammation, radiation therapy, frequent oral and injectable administration of aspirins, and anti-inflammatory drugs. If peptic ulcers are left untreated, they might initiate severe pain in the mid- or upper-body parts, weight loss, internal bleeding, and severe blood loss, which require hospitalization. Currently, they can be treated with various drug types, including proton pump inhibitors (PPI), H2 antagonists, antibiotics, potassium-competitive acid blockers (P-CAB), antacids, and ulcer protectives. These medications reduce body aches, provide more time to heal, minimize acid secretion, offer resistance against bacterial infections, and protect the stomach from digestive juices. As a result, peptic ulcer drugs are extensively utilized by healthcare practitioners for the treatment of gastritis, gastroesophageal reflux disease (GERD), and duodenal ulcers.

Peptic Ulcer Drugs Market Trends:

The increasing prevalence of peptic ulcers, especially amongst the geriatric population, represents one of the key factors driving the market growth. Moreover, unhealthy lifestyle habits and rising instances of stomach cancer, is resulting in the growing number of individuals suffering from peptic ulcers. This, along with the shifting consumer inclination towards various peptic ulcer-curing drugs over invasive surgeries, which, in turn, is contributing to the market growth. In line with this, as compared to surgical procedures, several steroidal anti-inflammatory medications are minimally invasive, more affordable, and enable faster recovery while ensuring reduced blood loss. Additionally, the ongoing approvals of peptic ulcer drugs and several government investments in pharmaceutical companies for the formulation of medications are supporting the market growth. This is further influenced by the continuous conduction of clinical trials for new drug formation to overcome complications and the ineffectiveness of present drugs in the market. Moreover, the increasing consumer awareness regarding the benefits of cost-effective peptic ulcer drugs and their easy availability across multiple distribution channels is favoring the market growth. The advent of artificial intelligence (AI)-based pathology testing technology to perform diagnostic and forensic operations is also propelling the market growth. Other factors, such as extensive research and development (R&D) activities to enhance product efficacy and the increasing investments in the development of the over the counter (OTC) medications for treating peptic ulcers, are positively impacting the market growth.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the global peptic ulcer drugs market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on product type, ulcer type, and distribution channel.

Product Type Insights:

  • Proton Pump Inhibitors
  • Potassium-Competitive Acid Blocker (P-CAB)
  • Antacids
  • H2-Antagonists
  • Antibiotics
  • Ulcer protective
The report has also provided a detailed breakup and analysis of the peptic ulcer drugs market based on the product type. This includes proton pump inhibitors, potassium-competitive acid blocker (P-CAB), antacids, H2-antagonists, antibiotics, and ulcer protective. According to the report, antibiotics represented the largest segment.

Ulcer Type Insights:

  • Gastric Ulcer
  • Duodenal Ulcer
  • Others
A detailed breakup and analysis of the peptic ulcer drugs market based on the ulcer type has also been provided in the report. This includes gastric ulcer, duodenal ulcer, and others. According to the report, duodenal ulcer accounted for the largest market share.

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
The report has also provided a detailed breakup and analysis of the peptic ulcer drugs market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for peptic ulcer drugs. Some of the factors driving the North America peptic ulcer drugs market included the increasing prevalence of peptic ulcers, especially amongst the geriatric population and shifting consumer inclination toward various peptic ulcer curing drugs over invasive surgeries and the fueling need for over-the-counter (OTC) medications in the healthcare sector.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global peptic ulcer drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, Novitium Pharma LLC, Pfizer Inc., PharmaKing Co. Ltd., RedHill Biopharma Ltd, Viatris Inc., Yuhan Corporation, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global peptic ulcer drugs market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global peptic ulcer drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive peptic ulcer drug markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the ulcer type?
  • What is the breakup of the market based on the distribution channel?
  • What is the competitive structure of the global peptic ulcer drugs market?
  • Who are the key players/companies in the global peptic ulcer drugs market?

Table of Contents

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Peptic Ulcer Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Proton Pump Inhibitors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Potassium-Competitive Acid Blocker (P-CAB)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Antacids
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 H2-Antagonists
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Antibiotics
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Ulcer Protective
6.6.1 Market Trends
6.6.2 Market Forecast

7 Market Breakup by Ulcer Type
7.1 Gastric Ulcer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Duodenal Ulcer
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AstraZeneca plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Boehringer Ingelheim International GmbH
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Novitium Pharma LLC
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Pfizer Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 PharmaKing Co. Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 RedHill Biopharma Ltd
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Viatris Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Yuhan Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Zydus Lifesciences Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures
Figure 1: Global: Peptic Ulcer Drugs Market: Major Drivers and Challenges
Figure 2: Global: Peptic Ulcer Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Peptic Ulcer Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Peptic Ulcer Drugs Market: Breakup by Product Type (in %), 2022
Figure 5: Global: Peptic Ulcer Drugs Market: Breakup by Ulcer Type (in %), 2022
Figure 6: Global: Peptic Ulcer Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Peptic Ulcer Drugs Market: Breakup by Region (in %), 2022
Figure 8: Global: Peptic Ulcer Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Peptic Ulcer Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Peptic Ulcer Drugs (Potassium-Competitive Acid Blocker (P-CAB)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Peptic Ulcer Drugs (Potassium-Competitive Acid Blocker (P-CAB)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Peptic Ulcer Drugs (Antacids) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Peptic Ulcer Drugs (Antacids) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Peptic Ulcer Drugs (H2-Antagonists) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Peptic Ulcer Drugs (H2-Antagonists) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Peptic Ulcer Drugs (Antibiotics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Peptic Ulcer Drugs (Antibiotics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Peptic Ulcer Drugs (Ulcer Protective) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Peptic Ulcer Drugs (Ulcer Protective) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Peptic Ulcer Drugs (Gastric Ulcer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Peptic Ulcer Drugs (Gastric Ulcer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Peptic Ulcer Drugs (Duodenal Ulcer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Peptic Ulcer Drugs (Duodenal Ulcer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Peptic Ulcer Drugs (Other Ulcer Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Peptic Ulcer Drugs (Other Ulcer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Peptic Ulcer Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Peptic Ulcer Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Peptic Ulcer Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Peptic Ulcer Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Peptic Ulcer Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Peptic Ulcer Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia-Pacific: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia-Pacific: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Peptic Ulcer Drugs Market: Breakup by Country (in %), 2022
Figure 80: Middle East and Africa: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Global: Peptic Ulcer Drugs Industry: Drivers, Restraints, and Opportunities
Figure 82: Global: Peptic Ulcer Drugs Industry: Value Chain Analysis
Figure 83: Global: Peptic Ulcer Drugs Industry: Porter's Five Forces Analysis

List of Tables
Table 1: Global: Peptic Ulcer Drugs Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Ulcer Type (in Million US$), 2023-2028
Table 4: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Peptic Ulcer Drugs Market: Competitive Structure
Table 7: Global: Peptic Ulcer Drugs Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Novitium Pharma LLC
  • Pfizer Inc.
  • PharmaKing Co. Ltd.
  • RedHill Biopharma Ltd
  • Viatris Inc.
  • Yuhan Corporation
  • Zydus Lifesciences Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Peptic Ulcer Drugs Market by Peptic Ulcer Type (Duodenal Ulcer, Gastric Ulcer), Drug Type (Cytoprotective Agents, H2 Blockers, Proton Pump Inhibitors (PPIs)), Distribution Channel - Forecast 2024-2030 - Product Image

Global Peptic Ulcer Drugs Market by Peptic Ulcer Type (Duodenal Ulcer, Gastric Ulcer), Drug Type (Cytoprotective Agents, H2 Blockers, Proton Pump Inhibitors (PPIs)), Distribution Channel - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Peptic Ulcer Drugs - Global Strategic Business Report - Product Image

Peptic Ulcer Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Peptic Ulcer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Image

Peptic Ulcer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • 92 Pages
  • Global
From
Anti Peptic Ulcer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Image

Anti Peptic Ulcer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • 95 Pages
  • Global
From
Proton Pump Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Proton Pump Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.